Medtech Big 100: Just missed the list
No. 101: Glaukos
Revenue:$282,862,000
研发expenditures:$123,271,000
Employees:783
CEO:Thomas Burns
HQ:Aliso Viejo, California
Glaukos ranked No. 95 in our 2022 Medtech Big 100 with $294 million in sales. Its drop from the 2023 ranking can be attributed to newcomers to the list and a decrease in its own sales. Glaukos develops ophthalmic medical devices for treating glaucoma, corneal disorders and retinal disease.
Medtech Big 100 analysis:Sales grow, jobs decrease, R&D spending climbs
Tell Us What You Think!
You must belogged into post a comment.